Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from ZYUS Life Sciences ( (TSE:ZYUS) ) is now available.
ZYUS Life Sciences Corporation has secured a CAD$1.5 million unsecured loan from an independent director, with the funds intended for general working capital. Additionally, the company has extended the maturity dates of its prior unsecured loans totaling CAD$5 million to March 28, 2027, in exchange for share purchase warrants, enhancing its financial flexibility and potentially impacting its market positioning.
More about ZYUS Life Sciences
ZYUS Life Sciences Corporation is a Canadian-based life sciences company that focuses on developing and commercializing novel cannabinoid-based pharmaceutical drug candidates for pain management.
YTD Price Performance: -12.09%
Average Trading Volume: 5,629
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: C$46.87M
For a thorough assessment of ZYUS stock, go to TipRanks’ Stock Analysis page.